Naomi E. Joffe
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Naomi E. Joffe has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Ahna L. Hoff Pai
The Research Institute at Nationwide Children’s Hospital, Columbus, United States
4 shared publications Kimberly L Klages
Division of Behavioral Medicine & Clinical Psychology, Cincinnati Children’s Hospital Medical Center , USA
3 shared publications- Marie L. Chardon
Division of Behavioral Medicine & Clinical Psychology, Cincinnati Children’s Hospital Medical Center , USA
3 shared publications - Anna Marie Hood
Manchester Centre for Health Psychology, Division of Psychology and Mental Health, University of Manchester , Manchester
2 shared publications Cara Nwankwo
Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio, United States
2 shared publications- Emily A. McTate
Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, USA
2 shared publications
Latest Publications
- Open Access
- 27 August 2026
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 73 (11) , e70650
Neuropsychological and Educational Outcomes in Shwachman–Diamond Syndrome—A Report From the North American Shwachman–Diamond Syndrome Registry
Background: Shwachman–Diamond syndrome (SDS) is a rare autosomal recessive ribosomopathy characterized by bone marrow failure and multisystem involvement, with emerging evidence of associated neurocognitive impairment. Methods: We conducted a retrospective study of 240 individuals with biallelic Shwachman–Bodian–Diamond syndrome (SBDS) mutations enrolled in the North American SDS Registry to characterize neuropsychological, psychiatric, educational, functional, and neuroimaging outcomes. Medical records were reviewed, and neuropsychological scores were converted to z ‐scores and categorized as weakness (1.0–1.4 SD below the mean) or impairment (≥1.5 SD below the mean). Results: Fourteen individuals completed formal neuropsychological evaluations (mean age 10.66 years). Median full‐scale IQ z ‐score was −0.47 (SD 1.28), with 41.7% demonstrating intellectual weakness or impairment. Adaptive functioning showed the highest rate of impairment (100%). Executive functioning, visual‐motor integration, spelling, and mathematics were commonly affected, whereas immediate verbal learning was preserved. Longitudinal data from five patients demonstrated stable overall intellectual and generally stable adaptive functioning over time, with variability in higher order cognitive and psychosocial domains. Educational support needs were substantial: 73.9% required specialized educational programs and 51.9% had an individualized education program. Neurodevelopmental disorders were reported in 49% of those with available data, most commonly attention‐deficit/hyperactivity disorder, and 23.5% had mental health diagnoses, most frequently anxiety. Neuroimaging was abnormal in a subset, most often reflecting structural brain differences. Conclusions: These findings indicate that individuals with SDS are at elevated risk for neurocognitive weaknesses and significant educational needs. Although global intellectual functioning appears relatively stable over time, domain‐specific vulnerabilities and adaptive impairment warrant routine neuropsychological monitoring and early intervention.
- 27 August 2026
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 73 (11) , e70650
Open AccessNeuropsychological and Educational Outcomes in Shwachman–Diamond Syndrome—A Report From the North American Shwachman–Diamond Syndrome Registry
Background: Shwachman–Diamond syndrome (SDS) is a rare autosomal recessive ribosomopathy characterized by bone marrow failure and multisystem involvement, with emerging evidence of associated neurocognitive impairment. Methods: We conducted a retrospective study of 240 individuals with biallelic Shwachman–Bodian–Diamond syndrome (SBDS) mutations enrolled in the North American SDS Registry to characterize neuropsychological, psychiatric, educational, functional, and neuroimaging outcomes. Medical records were reviewed, and neuropsychological scores were converted to z ‐scores and categorized as weakness (1.0–1.4 SD below the mean) or impairment (≥1.5 SD below the mean). Results: Fourteen individuals completed formal neuropsychological evaluations (mean age 10.66 years). Median full‐scale IQ z ‐score was −0.47 (SD 1.28), with 41.7% demonstrating intellectual weakness or impairment. Adaptive functioning showed the highest rate of impairment (100%). Executive functioning, visual‐motor integration, spelling, and mathematics were commonly affected, whereas immediate verbal learning was preserved. Longitudinal data from five patients demonstrated stable overall intellectual and generally stable adaptive functioning over time, with variability in higher order cognitive and psychosocial domains. Educational support needs were substantial: 73.9% required specialized educational programs and 51.9% had an individualized education program. Neurodevelopmental disorders were reported in 49% of those with available data, most commonly attention‐deficit/hyperactivity disorder, and 23.5% had mental health diagnoses, most frequently anxiety. Neuroimaging was abnormal in a subset, most often reflecting structural brain differences. Conclusions: These findings indicate that individuals with SDS are at elevated risk for neurocognitive weaknesses and significant educational needs. Although global intellectual functioning appears relatively stable over time, domain‐specific vulnerabilities and adaptive impairment warrant routine neuropsychological monitoring and early intervention.
- 15 November 2025
- Published by Oxford University Press (OUP) in Journal of Pediatric Psychology
- Vol. 51 (3) , 252-258
Costs of implementing a caregiver mental health program in a pediatric academic medical center: a budget impact analysis
Objective: Relatively few published guidelines on models of care to address the mental health needs of caregivers of patients with chronic illnesses exist. The purpose of this article is to conduct a budget impact analysis to estimate the costs associated with the implementation of a Caregiver Mental Health Program (CMHP) within the pediatric oncology and bone marrow transplant divisions at an academic medical center. Methods: Psychology labor costs were calculated for individuals involved in the delivery of the CMHP (4 licensed psychologists, 1 postdoctoral fellow) over a 1-year period. Caregiver and patient demographic and clinical data were extracted from the electronic medical record. A cost calculator was used to estimate labor costs associated with program operation. Results: Providers dedicated 629.23 hours to delivering the CMHP for a total of 60 caregivers during the 1-year study period. The most time was spent in session (66% of total hours), followed by supporting activities (21%), and documentation (13%). Total costs associated with the CMHP were estimated to be $51,395.35 across the five providers. Conclusions: This budget impact analysis is an important step in equipping relevant parties with information to estimate the financial consequences of the implementation of a CMHP. Limitations include the single-site nature of the study and the lack of information on other financial costs (e.g., start-up, administrative support). Future studies expanding this analysis to support the incorporation of billing/revenue data and caregiver outcomes will provide increased insight into the economic implications of CMHP service lines in pediatric academic medical centers.
- 15 November 2025
- Published by Oxford University Press (OUP) in Journal of Pediatric Psychology
- Vol. 51 (3) , 252-258
Costs of implementing a caregiver mental health program in a pediatric academic medical center: a budget impact analysis
Objective: Relatively few published guidelines on models of care to address the mental health needs of caregivers of patients with chronic illnesses exist. The purpose of this article is to conduct a budget impact analysis to estimate the costs associated with the implementation of a Caregiver Mental Health Program (CMHP) within the pediatric oncology and bone marrow transplant divisions at an academic medical center. Methods: Psychology labor costs were calculated for individuals involved in the delivery of the CMHP (4 licensed psychologists, 1 postdoctoral fellow) over a 1-year period. Caregiver and patient demographic and clinical data were extracted from the electronic medical record. A cost calculator was used to estimate labor costs associated with program operation. Results: Providers dedicated 629.23 hours to delivering the CMHP for a total of 60 caregivers during the 1-year study period. The most time was spent in session (66% of total hours), followed by supporting activities (21%), and documentation (13%). Total costs associated with the CMHP were estimated to be $51,395.35 across the five providers. Conclusions: This budget impact analysis is an important step in equipping relevant parties with information to estimate the financial consequences of the implementation of a CMHP. Limitations include the single-site nature of the study and the lack of information on other financial costs (e.g., start-up, administrative support). Future studies expanding this analysis to support the incorporation of billing/revenue data and caregiver outcomes will provide increased insight into the economic implications of CMHP service lines in pediatric academic medical centers.
- Open Access
- 29 September 2022
- Published by Oxford University Press (OUP) in Journal of Pediatric Psychology
- Vol. 48 (5) , 415-424
Pediatric Hematopoietic Stem Cell Transplant Medication Adherence Facilitators and Strategies: A Qualitative Study
Objective: Taking medications as prescribed after hematopoietic stem cell transplant (HCT) is key for ensuring children’s survival; however, suboptimal medication adherence is common. Development of evidence-based interventions to improve medication adherence post-HCT is contingent upon understanding what adherence facilitators (i.e., unique traits, characteristics, or resources inherent to the individual, medical treatment, or healthcare team) and strategies (i.e., tools caregivers or medical providers intentionally use) promote medication adherence in this population. Therefore, this study examined caregiver-perceived medication facilitators post-HCT. Methods: Semi-structured qualitative interviews and demographic questionnaires were completed by 29 caregivers of children (≤12 years) who had received an HCT within the past 2 years. Results: Thematic analysis guided by grounded theory revealed 14 saturated themes that were grouped into 4 categories: family facilitators, medication facilitators, caregiver strategies, and multidisciplinary treatment team strategies. Conclusions: Overall, findings suggest that caregivers of children who received an HCT are highly resourceful and independently develop many strategies to assist them with medication management after their child’s HCT. These facilitators and strategies varied between caregivers and over time. Despite prevalent facilitators and strategies, caregiver burden associated with medication adherence remains high. Caregivers may benefit from the multidisciplinary treatment team providing individualized and multicomponent (educational and behavioral) medication adherence supports to ease this burden particularly shortly after hospital discharge.
- 29 September 2022
- Published by Oxford University Press (OUP) in Journal of Pediatric Psychology
- Vol. 48 (5) , 415-424
Open AccessPediatric Hematopoietic Stem Cell Transplant Medication Adherence Facilitators and Strategies: A Qualitative Study
Objective: Taking medications as prescribed after hematopoietic stem cell transplant (HCT) is key for ensuring children’s survival; however, suboptimal medication adherence is common. Development of evidence-based interventions to improve medication adherence post-HCT is contingent upon understanding what adherence facilitators (i.e., unique traits, characteristics, or resources inherent to the individual, medical treatment, or healthcare team) and strategies (i.e., tools caregivers or medical providers intentionally use) promote medication adherence in this population. Therefore, this study examined caregiver-perceived medication facilitators post-HCT. Methods: Semi-structured qualitative interviews and demographic questionnaires were completed by 29 caregivers of children (≤12 years) who had received an HCT within the past 2 years. Results: Thematic analysis guided by grounded theory revealed 14 saturated themes that were grouped into 4 categories: family facilitators, medication facilitators, caregiver strategies, and multidisciplinary treatment team strategies. Conclusions: Overall, findings suggest that caregivers of children who received an HCT are highly resourceful and independently develop many strategies to assist them with medication management after their child’s HCT. These facilitators and strategies varied between caregivers and over time. Despite prevalent facilitators and strategies, caregiver burden associated with medication adherence remains high. Caregivers may benefit from the multidisciplinary treatment team providing individualized and multicomponent (educational and behavioral) medication adherence supports to ease this burden particularly shortly after hospital discharge.
- 1 March 2022
- Published by SAGE Publications in Clinical Practice in Pediatric Psychology
- Vol. 10 (1) , 79-90
Perceptions of a Self-Management Intervention for Adolescents With Sickle Cell Disease
Objective: Individuals with sickle cell disease (SCD) are at increased risk for complications from their disease during their adolescent and young adult (AYA) years. The risk of morbidity in AYAs with SCD can be decreased with improved self-management. Existing self-management interventions typically focus on one aspect of self-management (e.g., adherence) and do not address factors that activate patients (knowledge, motivation, self-efficacy, and social support) to self-manage. Sickle Cell Thrive (SCThrive) is a mixed in-person/online, technology-enhanced (use of a mobile app), group self-management intervention that targets patient activation. To determine the most clinically significant intervention components, a qualitative study was conducted. Method: Participants were 19 AYAs ( M age = 17.05) with SCD who participated in individual semistructured phone interviews after completing SCThrive. Interview content was coded using a grounded-theory approach to generate themes related to SCThrive’s feasibility, acceptability, and motivation for and impact on self-management. Results: SCThrive was reported to be highly feasible due to the mixed in-person/online format and acceptable because they learned skills to manage SCD in a group of AYAs with SCD. Action planning and pain/mood tracking appeared to be key factors in motivating AYAs for self-management. Participants reported continuing to use self-management skills post-SCThrive (self-efficacy) including applying them to other domains of their lives (e.g., educational/vocational). Conclusions: Study results provide data that can be leveraged to enhance the feasibility, acceptability, and impact of SCThrive and other self-management interventions. Findings can also inform clinical and mobile health interventions to increase self-management in this population. Implications for Impact Statement: Adolescents and young adults with sickle cell disease are a particularly vulnerable group at risk for serious disease complications that could be minimized or prevented with effective self-management. This study showed a self-management intervention delivered in a group format in-vivo and online was acceptable, feasible, and motivating for self-management. Participants perceived the peer support component and app as highly beneficial.
- 1 March 2022
- Published by SAGE Publications in Clinical Practice in Pediatric Psychology
- Vol. 10 (1) , 79-90
Perceptions of a Self-Management Intervention for Adolescents With Sickle Cell Disease
Objective: Individuals with sickle cell disease (SCD) are at increased risk for complications from their disease during their adolescent and young adult (AYA) years. The risk of morbidity in AYAs with SCD can be decreased with improved self-management. Existing self-management interventions typically focus on one aspect of self-management (e.g., adherence) and do not address factors that activate patients (knowledge, motivation, self-efficacy, and social support) to self-manage. Sickle Cell Thrive (SCThrive) is a mixed in-person/online, technology-enhanced (use of a mobile app), group self-management intervention that targets patient activation. To determine the most clinically significant intervention components, a qualitative study was conducted. Method: Participants were 19 AYAs ( M age = 17.05) with SCD who participated in individual semistructured phone interviews after completing SCThrive. Interview content was coded using a grounded-theory approach to generate themes related to SCThrive’s feasibility, acceptability, and motivation for and impact on self-management. Results: SCThrive was reported to be highly feasible due to the mixed in-person/online format and acceptable because they learned skills to manage SCD in a group of AYAs with SCD. Action planning and pain/mood tracking appeared to be key factors in motivating AYAs for self-management. Participants reported continuing to use self-management skills post-SCThrive (self-efficacy) including applying them to other domains of their lives (e.g., educational/vocational). Conclusions: Study results provide data that can be leveraged to enhance the feasibility, acceptability, and impact of SCThrive and other self-management interventions. Findings can also inform clinical and mobile health interventions to increase self-management in this population. Implications for Impact Statement: Adolescents and young adults with sickle cell disease are a particularly vulnerable group at risk for serious disease complications that could be minimized or prevented with effective self-management. This study showed a self-management intervention delivered in a group format in-vivo and online was acceptable, feasible, and motivating for self-management. Participants perceived the peer support component and app as highly beneficial.
- Open Access
- 23 January 2022
- Published by Oxford University Press (OUP) in Journal of Pediatric Psychology
- Vol. 47 (6) , 685-695
Caregivers’ Experience of Medication Adherence Barriers during Pediatric Hematopoietic Stem Cell Transplant: A Qualitative Study
Objective: Medications are critical for reducing morbidity and mortality risk in pediatric hematopoietic stem cell transplant (HCT). Nonetheless, medication adherence is suboptimal in this population. Identifying and managing barriers to medication management (i.e., medication barriers) is a key component of supporting medication adherence. However, understanding how medication barriers uniquely impact the pediatric HCT population and which barriers characterize each treatment stage remain unclear. Therefore, this study examined caregiver-perceived medication barriers over the course of pediatric HCT. Methods: Semi-structured qualitative interviews and demographic questionnaires were completed by 29 caregivers of children (≤12 years) who had received an HCT in the past 24 months and were either still admitted to, or had been discharged from, the hospital. Results: Grounded methodology revealed 21 qualitative themes grouped into 6 hierarchical categories. Findings reflected barriers to be present across HCT treatment but to differ based on treatment stage with only child medication refusal being a consistent barrier across all stages. Barriers were particularly prevalent after hospital discharge post-HCT when caregivers assumed full responsibility for medication management. In addition, families approaching hospital discharge often lacked insight about these post-discharge barriers such that they did not report anticipating the range of barriers described by caregivers who had already been discharged from the hospital and taken on full responsibility for medication management. Conclusions: Findings support the benefit of medication barrier assessment across HCT treatment. These results suggest that families may benefit from intervention to address the specific barriers they experience around medication adherence especially during the post-HCT outpatient period.
- 23 January 2022
- Published by Oxford University Press (OUP) in Journal of Pediatric Psychology
- Vol. 47 (6) , 685-695
Open AccessCaregivers’ Experience of Medication Adherence Barriers during Pediatric Hematopoietic Stem Cell Transplant: A Qualitative Study
Objective: Medications are critical for reducing morbidity and mortality risk in pediatric hematopoietic stem cell transplant (HCT). Nonetheless, medication adherence is suboptimal in this population. Identifying and managing barriers to medication management (i.e., medication barriers) is a key component of supporting medication adherence. However, understanding how medication barriers uniquely impact the pediatric HCT population and which barriers characterize each treatment stage remain unclear. Therefore, this study examined caregiver-perceived medication barriers over the course of pediatric HCT. Methods: Semi-structured qualitative interviews and demographic questionnaires were completed by 29 caregivers of children (≤12 years) who had received an HCT in the past 24 months and were either still admitted to, or had been discharged from, the hospital. Results: Grounded methodology revealed 21 qualitative themes grouped into 6 hierarchical categories. Findings reflected barriers to be present across HCT treatment but to differ based on treatment stage with only child medication refusal being a consistent barrier across all stages. Barriers were particularly prevalent after hospital discharge post-HCT when caregivers assumed full responsibility for medication management. In addition, families approaching hospital discharge often lacked insight about these post-discharge barriers such that they did not report anticipating the range of barriers described by caregivers who had already been discharged from the hospital and taken on full responsibility for medication management. Conclusions: Findings support the benefit of medication barrier assessment across HCT treatment. These results suggest that families may benefit from intervention to address the specific barriers they experience around medication adherence especially during the post-HCT outpatient period.
- Open Access
- 19 September 2021
- Published by Oxford University Press (OUP) in Journal of Pediatric Psychology
- Vol. 46 (10) , 1172-1181
Family Adjustment to Pediatric Hematopoietic Stem Cell Transplant During COVID-19
The COVID-19 pandemic has been difficult for families across the world due to fears about infection risk, increased social isolation, and significant changes in family roles and routines. Families with a child undergoing pediatric hematopoietic stem cell transplant (HCT) may be at even greater risk for poor adjustment during COVID-19 given their child’s increased risk for infection. The purpose of the current study was to qualitatively examine the impact of COVID-19 on family adjustment during pediatric HCT to inform clinical care. Twenty-nine caregivers of children (≤12 years) who underwent an HCT within the past 2 years completed semi-structured qualitative interviews and demographic questionnaires in the first 4 months following initial COVID-19 quarantine. Twenty-two themes emerged from the interviews using grounded theory methodology. Although nearly half of caregivers described COVID-19 as a stressor, 69% of caregivers reported adequate adjustment to COVID-19. Caregivers generally attributed their positive adjustment to HCT preparing the family for COVID-19 and more difficult adjustment to increased physical or social isolation and COVID-19 amplifying germ fears. The child’s HCT treatment status also had important implications on family adjustment to COVID-19. Results suggest that families undergoing pediatric HCT are uniquely prepared to cope with the impacts of a global pandemic; however, families experiencing certain risk factors (e.g., more recent transplant, impaired access to social support, reduced access to coping tools) may experience poorer adjustment during pandemics such as COVID-19 and may benefit from increased psychosocial support from their healthcare team.
- 19 September 2021
- Published by Oxford University Press (OUP) in Journal of Pediatric Psychology
- Vol. 46 (10) , 1172-1181
Open AccessFamily Adjustment to Pediatric Hematopoietic Stem Cell Transplant During COVID-19
The COVID-19 pandemic has been difficult for families across the world due to fears about infection risk, increased social isolation, and significant changes in family roles and routines. Families with a child undergoing pediatric hematopoietic stem cell transplant (HCT) may be at even greater risk for poor adjustment during COVID-19 given their child’s increased risk for infection. The purpose of the current study was to qualitatively examine the impact of COVID-19 on family adjustment during pediatric HCT to inform clinical care. Twenty-nine caregivers of children (≤12 years) who underwent an HCT within the past 2 years completed semi-structured qualitative interviews and demographic questionnaires in the first 4 months following initial COVID-19 quarantine. Twenty-two themes emerged from the interviews using grounded theory methodology. Although nearly half of caregivers described COVID-19 as a stressor, 69% of caregivers reported adequate adjustment to COVID-19. Caregivers generally attributed their positive adjustment to HCT preparing the family for COVID-19 and more difficult adjustment to increased physical or social isolation and COVID-19 amplifying germ fears. The child’s HCT treatment status also had important implications on family adjustment to COVID-19. Results suggest that families undergoing pediatric HCT are uniquely prepared to cope with the impacts of a global pandemic; however, families experiencing certain risk factors (e.g., more recent transplant, impaired access to social support, reduced access to coping tools) may experience poorer adjustment during pandemics such as COVID-19 and may benefit from increased psychosocial support from their healthcare team.
- Open Access
- 5 May 2021
- Published by Oxford University Press (OUP) in Translational Behavioral Medicine
- Vol. 11 (10) , 1823-1831
Mobile health use predicts self-efficacy and self-management in adolescents with sickle cell disease
Sickle cell disease (SCD) is associated with significant health challenges that often worsen during adolescence. Living with SCD requires a substantial amount of self-management and mobile health (mHealth) holds considerable promise for assessing and changing behaviors to improve health outcomes. We integrated a mobile app as an adjunct to a group intervention (SCThrive) and hypothesized that more engagement with the mHealth app would increase self-management and self-efficacy for adolescents and young adults (AYA) with SCD. Twenty-six AYA ages 13–21 years (54% female; 46% HbSS genotype; all African-American/Black) received six weekly group sessions (three in-person, three online). Participants were provided with the mobile app (iManage for SCD) to record progress on their self-management goals and log pain and mood symptoms. The Transition Readiness Assessment Questionnaire (TRAQ-5) assessed self-management skills and the Patient Activation Measure (PAM-13) assessed self-efficacy at baseline and post-treatment. Logging on to the app more frequently was associated higher mood ratings (r = .54, CI[.18, .77], p = .006) and lower pain ratings (r = −.48, CI[−.77, −.02], p = .04). Regression analyses demonstrated that after controlling for scores at baseline, the number of logins to the app predicted self-management skills (p = .05, η2 = .17) and possibly self-efficacy (p = .08, η2 = .13). Our study findings indicate that it can be challenging to maintain engagement in mHealth for AYA with SCD, but for those who do engage, there are significant benefits related to self-management, self-efficacy, and managing pain and mood.
- 5 May 2021
- Published by Oxford University Press (OUP) in Translational Behavioral Medicine
- Vol. 11 (10) , 1823-1831
Open AccessMobile health use predicts self-efficacy and self-management in adolescents with sickle cell disease
Sickle cell disease (SCD) is associated with significant health challenges that often worsen during adolescence. Living with SCD requires a substantial amount of self-management and mobile health (mHealth) holds considerable promise for assessing and changing behaviors to improve health outcomes. We integrated a mobile app as an adjunct to a group intervention (SCThrive) and hypothesized that more engagement with the mHealth app would increase self-management and self-efficacy for adolescents and young adults (AYA) with SCD. Twenty-six AYA ages 13–21 years (54% female; 46% HbSS genotype; all African-American/Black) received six weekly group sessions (three in-person, three online). Participants were provided with the mobile app (iManage for SCD) to record progress on their self-management goals and log pain and mood symptoms. The Transition Readiness Assessment Questionnaire (TRAQ-5) assessed self-management skills and the Patient Activation Measure (PAM-13) assessed self-efficacy at baseline and post-treatment. Logging on to the app more frequently was associated higher mood ratings (r = .54, CI[.18, .77], p = .006) and lower pain ratings (r = −.48, CI[−.77, −.02], p = .04). Regression analyses demonstrated that after controlling for scores at baseline, the number of logins to the app predicted self-management skills (p = .05, η2 = .17) and possibly self-efficacy (p = .08, η2 = .13). Our study findings indicate that it can be challenging to maintain engagement in mHealth for AYA with SCD, but for those who do engage, there are significant benefits related to self-management, self-efficacy, and managing pain and mood.
- 23 April 2020
- Published by Springer Nature in Journal of Clinical Psychology in Medical Settings
- Vol. 28 (2) , 323-330
Implementation of the Psychosocial Standards for Caregiver Mental Health Within a Pediatric Hematology/Oncology Program
The assessment of mental health needs and access to appropriate interventions for parents and caregivers is one of 15 evidence-based standards for the psychosocial care of children with cancer and their families. The objectives of this paper are to describe one program's approach to meeting this standard in oncologic, hematologic, and immunologic populations and outline key ethical, regulatory, and logistical considerations in providing mental health services to caregivers in a pediatric medical setting. A description of the Caregiver Mental Health Program (CMHP) is provided along with a case example to illustrate key considerations, including multiple family members needing care, access to psychiatric services, scope of treatment, confidentiality and privacy, and logistics. Challenges in the development of the CMHP as well as the program’s benefits are discussed. Implementation of this standard of care will vary across institutions depending on various factors, such as staffing and programmatic resources and institutional culture.
- 23 April 2020
- Published by Springer Nature in Journal of Clinical Psychology in Medical Settings
- Vol. 28 (2) , 323-330
Implementation of the Psychosocial Standards for Caregiver Mental Health Within a Pediatric Hematology/Oncology Program
The assessment of mental health needs and access to appropriate interventions for parents and caregivers is one of 15 evidence-based standards for the psychosocial care of children with cancer and their families. The objectives of this paper are to describe one program's approach to meeting this standard in oncologic, hematologic, and immunologic populations and outline key ethical, regulatory, and logistical considerations in providing mental health services to caregivers in a pediatric medical setting. A description of the Caregiver Mental Health Program (CMHP) is provided along with a case example to illustrate key considerations, including multiple family members needing care, access to psychiatric services, scope of treatment, confidentiality and privacy, and logistics. Challenges in the development of the CMHP as well as the program’s benefits are discussed. Implementation of this standard of care will vary across institutions depending on various factors, such as staffing and programmatic resources and institutional culture.